These medications interact with the brain reward system , energy metabolism , gastrointestinal function , and hormonal pathways that govern everything from appetite to arousal
To view or add a comment, sign in Glenmark Pharmaceuticals has launched GLIPIQ (semaglutide) in India, adding to the availability of GLP-1 receptor agonists used in the treatment of Type 2 diabetes
The goal remains optimizing diabetes management or weight loss while maintaining acceptable tolerability and patient well-being
Focus on the molecular mechanisms of cisplatin resistance based on multi-omics approaches
JourneyLite can help you compare medication, balloon, and surgical options so you can choose a treatment plan that fits your goals, your health, and your life
Ayuda a transformar la grasa en energa, favoreciendo el metabolismo y apoyando el rendimiento fsico